MOKAN Wealth Management Inc.

Position in LLY — ELI LILLY & Co

CIK 2053727 OVERLAND PARK, KS

Position in LLY

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$5,047,201

+$1,295,460 QoQ

Shares Held

4,208

+3.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.63%

of 13F equity value

Holder Rank

#1,711

of 4,605 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 6% None 94%

Healthcare · as of Jun 30, 2026

MOKAN Wealth Management Inc. holds $20,473,093 across 6 Drug Manufacturers - General names. LLY ranks #3 (24.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	48,990	$6,295,215
2	ABBV	AbbVie Inc.	23,835	$5,997,839
3	LLY	ELI LILLY & Co This page	4,208	$5,047,201
4	JNJ	Johnson & Johnson	5,872	$1,491,311
5	GILD	Gilead Sciences, Inc.	10,399	$1,313,809
6	AMGN	Amgen Inc	905	$327,718

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,047,201	4,208	+3.2%	Shares	Sole	2026-07-28
2026-03-31	$3,751,741	4,079	—	Shares	Sole	2026-05-01
No filing history on record for this holder in this stock.